Log In
BCIQ
Print this Print this
 

ATR-001

  Manage Alerts
Collapse Summary General Information
Company Atriva Therapeutics GmbH
DescriptionMEK inhibitor
Molecular Target MEK
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationInfluenza virus
Indication DetailsTreat influenza virus
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today